Company / Shareholders' Equity
Encompass Health Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$2.4B
FY2025
5-year range
$1.3B / $2.4B
FY2021-FY2025
Trend
+18.0%
vs FY2024
Sector context
#48 of 161
Health Care
What the data says
At $2.4B, Encompass Health's shareholders' equity ranks #48 of 161 in the Health Care sector. Shareholders' Equity has increased for 3 consecutive years, from $1.3B in FY2022 to $2.4B in FY2025.
Based on SEC 10-K filings.
$2.4B in FY2025 with a 5-year CAGR of +9.0%.
Improved from $1.6B to $2.4B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +23.0%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
#48 of 161 in Health CareTop 30% of 161This company $2.4B Sector average $5.1B
▼
-51.8% below sector average
Key checks
Key Insights
- Encompass Health's shareholders' equity has grown for 3 consecutive years.
- 5-year CAGR of +9.0%, indicating consistent growth.
- In FY2025, shareholders' equity increased 18.0% year-over-year.
- Ranks #48 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4B | +18.0% |
| FY2024 | $2.1B | +25.5% |
| FY2023 | $1.6B | +25.7% |
| FY2022 | $1.3B | -31.4% |
| FY2021 | $1.9B | +20.4% |
| FY2020 | $1.6B | +17.4% |
| FY2019 | $1.4B | +5.9% |
| FY2018 | $1.3B | -8.5% |
| FY2017 | $1.4B | +53.2% |
| FY2016 | $910.6M | +19.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026